Rational design of high affinity tachykinin NK2 receptor antagonists
- 28 February 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 2 (2) , 101-113
- https://doi.org/10.1016/s0968-0896(00)82006-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Rationally designed ‘dipeptoid’ analogues of cholecystokinin (CCK): N-terminal structure-affinity relationships of α-methyl-tryptophan derivativesEuropean Journal of Medicinal Chemistry, 1993
- The design of a dipeptide library for screening at peptide receptor sitesBioorganic & Medicinal Chemistry Letters, 1993
- Ophthalmology in GhanaSeminars in Ophthalmology, 1993
- Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pigBritish Journal of Pharmacology, 1992
- Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic propertiesJournal of Medicinal Chemistry, 1991
- Pharmacological specificity of synthetic peptides as antagonists at tachykinin receptorsRegulatory Peptides, 1988
- Agonist and antagonist binding to tachykinin peptide NK-2 receptorsLife Sciences, 1988
- Analogs of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effectsJournal of Medicinal Chemistry, 1986
- Chemical design of antagonists of substance PActa Physiologica Scandinavica, 1981
- Isosterism and molecular modification in drug designChemical Society Reviews, 1979